4//SEC Filing
Whitehead Warren 4
Accession 0001567619-21-000664
CIK 0000882361other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:46 PM ET
Size
5.9 KB
Accession
0001567619-21-000664
Insider Transaction Report
Form 4
Whitehead Warren
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-01-04+50,000→ 50,000 totalExercise: $4.38Exp: 2031-01-04→ Common Shares (50,000 underlying)
Footnotes (2)
- [F1]Converted from Canadian exercise price of C$5.58 using an exchange rate of C$1.2751 = US$1.00.
- [F2]The options were granted on January 4, 2021, and vest as follows: 50% vest on January 4, 2022; 25% vest on January 4, 2023; and 25% vest on January 4, 2024.
Documents
Issuer
Aptose Biosciences Inc.
CIK 0000882361
Entity typeother
Related Parties
1- filerCIK 0001761449
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:46 PM ET
- Size
- 5.9 KB